T2 Biosystems Demonstrates First-Ever Ability to Accurately and Rapidly Detect Systemic Candida Infection Directly in Whole Blood in Single-Process Test MIR Acquisition Seals $7M in Series A Financing Genta Initiates Tesetaxel Clinical Trial in Japan to Kickoff Comprehensive Development Program in East Asia TRACON Pharmaceuticals announces $22 million tranched investment led by JAFCO and Nextech to fund TRC105 Phase 2 development Genta Tesetaxel Results from Multiple Dose-Ranging Clinical Trials Updated at ASCO Genta Tesetaxel Results as Initial Chemotherapy for Women with Breast Cancer Presented at ASCO Genta Phase 3 Trial of Genasense® in Advanced Melanoma Does Not Show Significant Increase in Overall Survival Genta Initiates Trial with Tesetaxel as First- and Second-Line Chemotherapy for Patients with Advanced Prostate Cancer MacroGenics hits winning target Vascular Pathways raises $14M Palyon Medical Corporation Secures $21 Million in Series A Investment